The North America Facial Injectable Market would witness market growth of 8.9% CAGR during the forecast period (2023-2029).
There has been a significant rise in disposable incomes as well as a development in awareness of aesthetic beauty. As more & more people want to enhance their aesthetic appearances, this has changed attitudes toward cosmetic operations. Many people choose face injectables over minimally invasive procedures since they are considered safer and have little to no downtime. These injectables include dermal fillers like hyaluronic acid and calcium hydroxylapatite and neurotoxins like botulinum toxin and hyaluronic acid.
The engagement of prominent companies has expanded due to these encouraging tendencies toward wider use of facial injectables. As a result, these businesses have invested in several R&D projects to create cutting-edge fillers that cater to the unmet demands of their clientele. Along with a rise in procedure volumes, this has resulted in the introduction of several unique products. During the projected period, these favorable aspects are anticipated to significantly impact market growth. Furthermore, the increased use of these items across all demographic groups is a crucial trend anticipated to fuel market expansion.
The ageing population in the US and the desire to maintain one's social and economic mobility are primarily responsible for the country's increased demand for aesthetic operations. Therefore, people between 35 and 50 undergo skin tightening and rejuvenation procedures as preventative steps. Men are also becoming much more popular with aesthetic procedures. To increase their revenue share in the regional market, market players are also focusing on introducing innovative products. As a result, the North American market for facial injectables is anticipated to expand significantly during the forecast period.
The US market dominated the North America Facial Injectable Market by Country in 2022 thereby, achieving a market value of $6,116.7 Million by 2029. The Canada market is showcasing a CAGR of 11.4% during (2023 - 2029). Additionally, The Mexico market would register a CAGR of 10.4% during (2023 - 2029).
Based on End-use, the market is segmented into MedSpa, Dermatology Clinics and Hospitals. Based on Product, the market is segmented into Botulinum Toxin Type A, Calcium Hydroxylapatite (CaHA), Poly-L-Lactic Acid (PLLA), Collagen & PMMA Microspheres, Hyaluronic Acid (HA) and Others. Based on Application, the market is segmented into Facial Line Correction, Face Lift, Lip Augmentation, Acne Scar Treatment, Lipoatrophy Treatment and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Worldwide Facial Injectable Market is Projected to reach USD 22.5 Billion by 2029, at a CAGR of 10.1%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Ipsen Pharma Biotech SAS, Merz Pharma GmbH & Co. KGaA, Suneva Medical, Inc., Medytox Inc., Sinclair Pharma Ltd., Bloomage Biotechnology Corporation Limited (Bloomage International Investment Group), Anika Therapeutics, Inc., Prollenium Medical Technologies Inc., Galderma S.A., and Allergan PLC (AbbVie, Inc.).
Scope of the Study
Market Segments Covered in the Report:
By End-use
- MedSpa
- Dermatology Clinics
- Hospitals
By Product
- Botulinum Toxin Type A
- Calcium Hydroxylapatite (CaHA)
- Poly-L-Lactic Acid (PLLA)
- Collagen & PMMA Microspheres
- Hyaluronic Acid (HA)
- Others
By Application
- Facial Line Correction
- Face Lift
- Lip Augmentation
- Acne Scar Treatment
- Lipoatrophy Treatment
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Ipsen Pharma Biotech SAS
- Merz Pharma GmbH & Co. KGaA
- Suneva Medical, Inc.
- Medytox Inc.
- Sinclair Pharma Ltd.
- Bloomage Biotechnology Corporation Limited (Bloomage International Investment Group)
- Anika Therapeutics, Inc.
- Prollenium Medical Technologies Inc.
- Galderma S.A.
- Allergan PLC (AbbVie, Inc.)
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Facial Injectable Market, by End-use
1.4.2 North America Facial Injectable Market, by Product
1.4.3 North America Facial Injectable Market, by Application
1.4.4 North America Facial Injectable Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Facial Injectable Market by End-use
3.1 North America MedSpa Market by Country
3.2 North America Dermatology Clinics Market by Country
3.3 North America Hospitals Market by Country
Chapter 4. North America Facial Injectable Market by Product
4.1 North America Botulinum Toxin Type A Market by Country
4.2 North America Calcium Hydroxylapatite (CaHA) Market by Country
4.3 North America Poly-L-Lactic Acid (PLLA) Market by Country
4.4 North America Collagen & PMMA Microspheres Market by Country
4.5 North America Hyaluronic Acid (HA) Market by Country
4.6 North America Others Market by Country
Chapter 5. North America Facial Injectable Market by Application
5.1 North America Facial Line Correction Market by Country
5.2 North America Face Lift Market by Country
5.3 North America Lip Augmentation Market by Country
5.4 North America Acne Scar Treatment Market by Country
5.5 North America Lipoatrophy Treatment Market by Country
5.6 North America Others Market by Country
Chapter 6. North America Facial Injectable Market by Country
6.1 US Facial Injectable Market
6.1.1 US Facial Injectable Market by End-use
6.1.2 US Facial Injectable Market by Product
6.1.3 US Facial Injectable Market by Application
6.2 Canada Facial Injectable Market
6.2.1 Canada Facial Injectable Market by End-use
6.2.2 Canada Facial Injectable Market by Product
6.2.3 Canada Facial Injectable Market by Application
6.3 Mexico Facial Injectable Market
6.3.1 Mexico Facial Injectable Market by End-use
6.3.2 Mexico Facial Injectable Market by Product
6.3.3 Mexico Facial Injectable Market by Application
6.4 Rest of North America Facial Injectable Market
6.4.1 Rest of North America Facial Injectable Market by End-use
6.4.2 Rest of North America Facial Injectable Market by Product
6.4.3 Rest of North America Facial Injectable Market by Application
Chapter 7. Company Profiles
7.1 Ipsen Pharma Biotech SAS
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Regional Analysis
7.1.4 Research & Development Expense
7.2 Merz Pharma GmbH & Co. KGaA
7.2.1 Company Overview
7.2.2 Recent strategies and developments:
7.2.2.1 Partnerships, Collaborations, and Agreements:
7.2.2.2 Product Launches and Product Expansions:
7.3 Suneva Medical, Inc.
7.3.1 Company Overview
7.4 Medytox Inc.
7.4.1 Company Overview
7.5 Sinclair Pharma Ltd. (Huadong Medicine Co., Ltd.)
7.5.1 Company Overview
7.5.2 Recent strategies and developments:
7.5.2.1 Product Launches and Product Expansions:
7.5.2.2 Approvals and Trials:
7.6 Bloomage Biotechnology Corporation Limited (Bloomage International Investment Group)
7.6.1 Company Overview
7.7 Anika Therapeutics, Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expenses
7.8 Prollenium Medical Technologies Inc.
7.8.1 Company Overview
7.8.2 Recent strategies and developments:
7.8.2.1 Acquisition and Mergers:
7.9 Galderma S.A.
7.9.1 Company Overview
7.9.2 Recent strategies and developments:
7.9.2.1 Partnerships, Collaborations, and Agreements:
7.9.2.2 Acquisition and Mergers:
7.10. Allergan PLC (AbbVie, Inc.)
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Regional Analysis
7.10.4 Research & Development Expense
TABLE 1 North America Facial Injectable Market, 2019 - 2022, USD Million
TABLE 2 North America Facial Injectable Market, 2023 - 2029, USD Million
TABLE 3 North America Facial Injectable Market by End-use, 2019 - 2022, USD Million
TABLE 4 North America Facial Injectable Market by End-use, 2023 - 2029, USD Million
TABLE 5 North America MedSpa Market by Country, 2019 - 2022, USD Million
TABLE 6 North America MedSpa Market by Country, 2023 - 2029, USD Million
TABLE 7 North America Dermatology Clinics Market by Country, 2019 - 2022, USD Million
TABLE 8 North America Dermatology Clinics Market by Country, 2023 - 2029, USD Million
TABLE 9 North America Hospitals Market by Country, 2019 - 2022, USD Million
TABLE 10 North America Hospitals Market by Country, 2023 - 2029, USD Million
TABLE 11 North America Facial Injectable Market by Product, 2019 - 2022, USD Million
TABLE 12 North America Facial Injectable Market by Product, 2023 - 2029, USD Million
TABLE 13 North America Botulinum Toxin Type A Market by Country, 2019 - 2022, USD Million
TABLE 14 North America Botulinum Toxin Type A Market by Country, 2023 - 2029, USD Million
TABLE 15 North America Calcium Hydroxylapatite (CaHA) Market by Country, 2019 - 2022, USD Million
TABLE 16 North America Calcium Hydroxylapatite (CaHA) Market by Country, 2023 - 2029, USD Million
TABLE 17 North America Poly-L-Lactic Acid (PLLA) Market by Country, 2019 - 2022, USD Million
TABLE 18 North America Poly-L-Lactic Acid (PLLA) Market by Country, 2023 - 2029, USD Million
TABLE 19 North America Collagen & PMMA Microspheres Market by Country, 2019 - 2022, USD Million
TABLE 20 North America Collagen & PMMA Microspheres Market by Country, 2023 - 2029, USD Million
TABLE 21 North America Hyaluronic Acid (HA) Market by Country, 2019 - 2022, USD Million
TABLE 22 North America Hyaluronic Acid (HA) Market by Country, 2023 - 2029, USD Million
TABLE 23 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 24 North America Others Market by Country, 2023 - 2029, USD Million
TABLE 25 North America Facial Injectable Market by Application, 2019 - 2022, USD Million
TABLE 26 North America Facial Injectable Market by Application, 2023 - 2029, USD Million
TABLE 27 North America Facial Line Correction Market by Country, 2019 - 2022, USD Million
TABLE 28 North America Facial Line Correction Market by Country, 2023 - 2029, USD Million
TABLE 29 North America Face Lift Market by Country, 2019 - 2022, USD Million
TABLE 30 North America Face Lift Market by Country, 2023 - 2029, USD Million
TABLE 31 North America Lip Augmentation Market by Country, 2019 - 2022, USD Million
TABLE 32 North America Lip Augmentation Market by Country, 2023 - 2029, USD Million
TABLE 33 North America Acne Scar Treatment Market by Country, 2019 - 2022, USD Million
TABLE 34 North America Acne Scar Treatment Market by Country, 2023 - 2029, USD Million
TABLE 35 North America Lipoatrophy Treatment Market by Country, 2019 - 2022, USD Million
TABLE 36 North America Lipoatrophy Treatment Market by Country, 2023 - 2029, USD Million
TABLE 37 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 38 North America Others Market by Country, 2023 - 2029, USD Million
TABLE 39 North America Facial Injectable Market by Country, 2019 - 2022, USD Million
TABLE 40 North America Facial Injectable Market by Country, 2023 - 2029, USD Million
TABLE 41 US Facial Injectable Market, 2019 - 2022, USD Million
TABLE 42 US Facial Injectable Market, 2023 - 2029, USD Million
TABLE 43 US Facial Injectable Market by End-use, 2019 - 2022, USD Million
TABLE 44 US Facial Injectable Market by End-use, 2023 - 2029, USD Million
TABLE 45 US Facial Injectable Market by Product, 2019 - 2022, USD Million
TABLE 46 US Facial Injectable Market by Product, 2023 - 2029, USD Million
TABLE 47 US Facial Injectable Market by Application, 2019 - 2022, USD Million
TABLE 48 US Facial Injectable Market by Application, 2023 - 2029, USD Million
TABLE 49 Canada Facial Injectable Market, 2019 - 2022, USD Million
TABLE 50 Canada Facial Injectable Market, 2023 - 2029, USD Million
TABLE 51 Canada Facial Injectable Market by End-use, 2019 - 2022, USD Million
TABLE 52 Canada Facial Injectable Market by End-use, 2023 - 2029, USD Million
TABLE 53 Canada Facial Injectable Market by Product, 2019 - 2022, USD Million
TABLE 54 Canada Facial Injectable Market by Product, 2023 - 2029, USD Million
TABLE 55 Canada Facial Injectable Market by Application, 2019 - 2022, USD Million
TABLE 56 Canada Facial Injectable Market by Application, 2023 - 2029, USD Million
TABLE 57 Mexico Facial Injectable Market, 2019 - 2022, USD Million
TABLE 58 Mexico Facial Injectable Market, 2023 - 2029, USD Million
TABLE 59 Mexico Facial Injectable Market by End-use, 2019 - 2022, USD Million
TABLE 60 Mexico Facial Injectable Market by End-use, 2023 - 2029, USD Million
TABLE 61 Mexico Facial Injectable Market by Product, 2019 - 2022, USD Million
TABLE 62 Mexico Facial Injectable Market by Product, 2023 - 2029, USD Million
TABLE 63 Mexico Facial Injectable Market by Application, 2019 - 2022, USD Million
TABLE 64 Mexico Facial Injectable Market by Application, 2023 - 2029, USD Million
TABLE 65 Rest of North America Facial Injectable Market, 2019 - 2022, USD Million
TABLE 66 Rest of North America Facial Injectable Market, 2023 - 2029, USD Million
TABLE 67 Rest of North America Facial Injectable Market by End-use, 2019 - 2022, USD Million
TABLE 68 Rest of North America Facial Injectable Market by End-use, 2023 - 2029, USD Million
TABLE 69 Rest of North America Facial Injectable Market by Product, 2019 - 2022, USD Million
TABLE 70 Rest of North America Facial Injectable Market by Product, 2023 - 2029, USD Million
TABLE 71 Rest of North America Facial Injectable Market by Application, 2019 - 2022, USD Million
TABLE 72 Rest of North America Facial Injectable Market by Application, 2023 - 2029, USD Million
TABLE 73 Key Information – Ipsen Pharma Biotech SAS
TABLE 74 Key information – Merz Pharma GmbH & Co. KGaA
TABLE 75 Key Information – Suneva Medical, Inc.
TABLE 76 Key Information – Medytox Inc.
TABLE 77 Key Information – Sinclair Pharma Ltd.
TABLE 78 Key Information – Bloomage Biotechnology Corporation Limited
TABLE 79 Key Information – Anika Therapeutics, Inc.
TABLE 80 Key Information – Prollenium Medical Technologies Inc.
TABLE 81 Key Information – Galderma S.A.
TABLE 82 Key Information – Allergan PLC
List of Figures
FIG 1 Methodology for the research
FIG 2 North America Facial Injectable Market Share by End-use, 2022
FIG 3 North America Facial Injectable Market Share by End-use, 2029
FIG 4 North America Facial Injectable Market by End-use, 2019 - 2029, USD Million
FIG 5 North America Facial Injectable Market Share by Product, 2022
FIG 6 North America Facial Injectable Market Share by Product, 2029
FIG 7 North America Facial Injectable Market by Product, 2019 - 2029, USD Million
FIG 8 North America Facial Injectable Market Share by Application, 2022
FIG 9 North America Facial Injectable Market Share by Application, 2029
FIG 10 North America Facial Injectable Market by Application, 2019 - 2029, USD Million
FIG 11 North America Facial Injectable Market Share by Country, 2022
FIG 12 North America Facial Injectable Market Share by Country, 2029
FIG 13 North America Facial Injectable Market by Country, 2019 - 2029, USD Million
FIG 14 Recent strategies and developments: Merz Pharma GmbH & Co. KGaA